Growth Hormone Deficiency Global Clinical Trials Review H1 2015


#308798

93pages

GlobalData

$ 2500

In Stock

Growth Hormone Deficiency Global Clinical Trials Review, H1, 2015

Summary

GlobalData's clinical trial report, Growth Hormone Deficiency Global Clinical Trials Review, H1, 2015" provides an overview of Growth Hormone Deficiency clinical trials scenario. This report provides top line data relating to the clinical trials on Growth Hormone Deficiency . Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Datas proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Growth Hormone Deficiency 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Growth Hormone Deficiency to Metabolic Disorders Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Growth Hormone Deficiency to Metabolic Disorders Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Growth Hormone Deficiency 25
Subjects Recruited Over a Period of Time 29
Clinical Trials by Sponsor Type 30
Prominent Sponsors 31
Top Companies Participating in Growth Hormone Deficiency Therapeutics Clinical Trials 32
Prominent Drugs 33
Latest Clinical Trials News on Growth Hormone Deficiency 34
Jun 25, 2015: Aeterna Zentaris Announces Selection of Ergomed to Conduct Confirmatory Phase 3 Clinical Trial of Macrilen in AGHD 34
May 26, 2015: Aeterna Zentaris Confirmatory Phase 3 Study for Macrilen in AGHD Meets EMAs Study-Design Expectations 34
Apr 13, 2015: Aeterna Zentaris Announces Plans to Initiate Phase 3 Study of Macrilen in AGHD Following Successful Meeting with FDA 35
Apr 13, 2015: Versartis Initiates Phase 2/3 Trial of VRS-317 in Japan for Children With Growth Hormone Deficiency 35
Clinical Trial Profiles 37
Clinical Trial Overview of Top Companies 37
Novo A/S 37
Clinical Trial Overview of Novo A/S 37
Pfizer Inc. 40
Clinical Trial Overview of Pfizer Inc. 40
Eli Lilly and Company 42
Clinical Trial Overview of Eli Lilly and Company 42
F. Hoffmann-La Roche Ltd. 43
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 43
Canbex Therapeutics Ltd. 44
Clinical Trial Overview of Canbex Therapeutics Ltd. 44
E. Merck KG 45
Clinical Trial Overview of E. Merck KG 45
LG Life Sciences, Ltd. 46
Clinical Trial Overview of LG Life Sciences, Ltd. 46
Ferring International Center S.A. 47
Clinical Trial Overview of Ferring International Center S.A. 47
Teva Pharmaceutical Industries Limited 48
Clinical Trial Overview of Teva Pharmaceutical Industries Limited 48
OPKO Health, Inc. 49
Clinical Trial Overview of OPKO Health, Inc. 49
Clinical Trial Overview of Top Institutes / Government 50
Aarhus University 50
Clinical Trial Overview of Aarhus University 50
Federico II University 51
Clinical Trial Overview of Federico II University 51
Massachusetts General Hospital 52
Clinical Trial Overview of Massachusetts General Hospital 52
Oregon Health & Science University 53
Clinical Trial Overview of Oregon Health & Science University 53
Columbia University 54
Clinical Trial Overview of Columbia University 54
Eunice Kennedy Shriver National Institute of Child Health and Human Development 55
Clinical Trial Overview of Eunice Kennedy Shriver National Institute of Child Health and Human Development 55
Sahlgrenska University Hospital 56
Clinical Trial Overview of Sahlgrenska University Hospital 56
University of Pennsylvania 57
Clinical Trial Overview of University of Pennsylvania 57
Aarhus University Hospital 58
Clinical Trial Overview of Aarhus University Hospital 58
Assaf-Harofeh Medical Center 59
Clinical Trial Overview of Assaf-Harofeh Medical Center 59
Five Key Clinical Profiles 60
Appendix 90
Abbreviations 90
Definitions 90
Research Methodology 91
Secondary Research 91
About GlobalData 92
Contact Us 92
Disclaimer 92
Source 93

List of Tables
Growth Hormone Deficiency Therapeutics, Global, Clinical Trials by Region, 2015* 7
Growth Hormone Deficiency Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Growth Hormone Deficiency Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Growth Hormone Deficiency Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Growth Hormone Deficiency Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Growth Hormone Deficiency Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Growth Hormone Deficiency Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015* 13
Growth Hormone Deficiency Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14
Proportion of Growth Hormone Deficiency to Metabolic Disorders Clinical Trials, G7 Countries (%), 2015* 15
Growth Hormone Deficiency Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Growth Hormone Deficiency Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Growth Hormone Deficiency to Metabolic Disorders Clinical Trials, E7 Countries (%), 2015* 18
Growth Hormone Deficiency Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Growth Hormone Deficiency Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Growth Hormone Deficiency Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Growth Hormone Deficiency Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Growth Hormone Deficiency Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Growth Hormone Deficiency Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Growth Hormone Deficiency Therapeutics, Global, Suspended Clinical Trials, 2015* 25
Growth Hormone Deficiency Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26
Growth Hormone Deficiency Therapeutics, Global, Terminated Clinical Trials, 2015* 27
Growth Hormone Deficiency Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 29
Growth Hormone Deficiency Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 30
Growth Hormone Deficiency Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 31
Growth Hormone Deficiency Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 32
Growth Hormone Deficiency Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 33
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Novo A/S, 2015* 37
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 40
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2015* 42
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015* 43
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Canbex Therapeutics Ltd., 2015* 44
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by E. Merck KG, 2015* 45
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by LG Life Sciences, Ltd., 2015* 46
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Ferring International Center S.A., 2015* 47
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Teva Pharmaceutical Industries Limited, 2015* 48
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by OPKO Health, Inc., 2015* 49
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Aarhus University, 2015* 50
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Federico II University, 2015* 51
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2015* 52
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Oregon Health & Science University, 2015* 53
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Columbia University, 2015* 54
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Eunice Kennedy Shriver National Institute of Child Health and Human Development, 2015* 55
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Sahlgrenska University Hospital, 2015* 56
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pennsylvania, 2015* 57
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Aarhus University Hospital, 2015* 58
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Assaf-Harofeh Medical Center, 2015* 59

List of Figures
Growth Hormone Deficiency Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Growth Hormone Deficiency Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Growth Hormone Deficiency Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Growth Hormone Deficiency Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Growth Hormone Deficiency Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Growth Hormone Deficiency Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Growth Hormone Deficiency Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015* 13
Growth Hormone Deficiency Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 14
Proportion of Growth Hormone Deficiency to Metabolic Disorders Clinical Trials, G7 Countries (%), 2015* 15
Growth Hormone Deficiency Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Growth Hormone Deficiency Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Growth Hormone Deficiency to Metabolic Disorders Clinical Trials, E7 Countries (%), 2015* 18
Growth Hormone Deficiency Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Growth Hormone Deficiency Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Growth Hormone Deficiency Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Growth Hormone Deficiency Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Growth Hormone Deficiency Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Growth Hormone Deficiency Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Growth Hormone Deficiency Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 29
Growth Hormone Deficiency Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 30
Growth Hormone Deficiency Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 31
Growth Hormone Deficiency Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 32
Growth Hormone Deficiency Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 33
GlobalData Methodology 91